Axsome Therapeutics, Inc.
AXSM
주식 순위
#2390
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
주가
$157.29
마지막 동기화: 2026-10-16
시가총액
$8.24B
변동 (1일)
-2.78%
변동 (1년)
22.94%
국가
US
거래 Axsome Therapeutics, Inc. (AXSM)
카테고리
Healthcare
Axsome Therapeutics, Inc. (AXSM)의 영업이익률
October 2026 기준 영업이익률 TTM: -24.28%
Axsome Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 -24.28%입니다. 2023년 말 기준 영업이익률은 -85.67%였습니다.
Axsome Therapeutics, Inc.의 영업이익률 기록 (2013 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | -24.28% | -66.62% |
| 2024 | -72.74% | -15.09% |
| 2023 | -85.67% | -75.71% |
| 2022 | -352.74% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 38.59% | -101.59% |
US
|
|
| -149.01% | -93.86% |
US
|
|
| 25.57% | -101.05% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.19% |
NL
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.